Agilon Health Inc (AGL)
6.30
+0.06
(+0.96%)
USD |
NYSE |
May 31, 16:00
6.305
0.00 (0.00%)
Pre-Market: 20:00
Agilon Health Enterprise Value: 2.208B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 2.208B |
| May 30, 2024 | 2.184B |
| May 29, 2024 | 1.986B |
| May 28, 2024 | 2.130B |
| May 24, 2024 | 2.122B |
| May 23, 2024 | 1.941B |
| May 22, 2024 | 2.081B |
| May 21, 2024 | 1.900B |
| May 20, 2024 | 1.822B |
| May 17, 2024 | 1.842B |
| May 16, 2024 | 1.912B |
| May 15, 2024 | 1.797B |
| May 14, 2024 | 1.879B |
| May 13, 2024 | 1.760B |
| May 10, 2024 | 1.752B |
| May 09, 2024 | 1.781B |
| May 08, 2024 | 1.752B |
| May 07, 2024 | 1.666B |
| May 06, 2024 | 1.604B |
| May 03, 2024 | 1.604B |
| May 02, 2024 | 1.604B |
| May 01, 2024 | 1.657B |
| April 30, 2024 | 1.878B |
| April 29, 2024 | 1.726B |
| April 26, 2024 | 1.673B |
| Date | Value |
|---|---|
| April 25, 2024 | 1.726B |
| April 24, 2024 | 1.808B |
| April 23, 2024 | 1.813B |
| April 22, 2024 | 1.739B |
| April 19, 2024 | 1.862B |
| April 18, 2024 | 1.829B |
| April 17, 2024 | 1.677B |
| April 16, 2024 | 1.459B |
| April 15, 2024 | 1.451B |
| April 12, 2024 | 1.652B |
| April 11, 2024 | 1.808B |
| April 10, 2024 | 1.837B |
| April 09, 2024 | 1.903B |
| April 08, 2024 | 1.747B |
| April 05, 2024 | 1.570B |
| April 04, 2024 | 1.607B |
| April 03, 2024 | 1.569B |
| April 02, 2024 | 1.705B |
| April 01, 2024 | 2.017B |
| March 31, 2024 | 2.124B |
| March 28, 2024 | 2.048B |
| March 27, 2024 | 1.896B |
| March 26, 2024 | 1.593B |
| March 25, 2024 | 1.499B |
| March 22, 2024 | 1.552B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.451B
Minimum
Apr 15 2024
16.90B
Maximum
Jun 18 2021
7.599B
Average
7.493B
Median
Enterprise Value Benchmarks
| Sonida Senior Living Inc | 986.70M |
| InnovAge Holding Corp | 589.10M |
| National Healthcare Corp | 1.413B |
| Astrana Health Inc | 1.735B |
| The Oncology Institute Inc | 59.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.064M |
| Revenue (Quarterly) | 1.604B |
| Total Expenses (Quarterly) | 1.612B |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 4.68% |
| Profit Margin (Quarterly) | -0.38% |
| Earnings Yield | -10.95% |
| Normalized Earnings Yield | -8.095 |